Literature DB >> 9362266

Taurine depletion, a novel mechanism for cardioprotection from regional ischemia.

S N Allo1, L Bagby, S W Schaffer.   

Abstract

Three processes that have been implicated in ischemic injury are impaired Ca2+ movement, altered osmoregulation, and membrane remodeling. Because the amino acid, taurine, affects all three processes, it seemed logical that changes in the myocardial content of taurine might affect ischemic injury. To test this hypothesis, infarct size and areas at risk were compared in isolated hearts from control and taurine-depleted rats after a 45-min ligation of the left anterior descending coronary artery and 2 h of reperfusion. Hearts of rats treated for 4 wk with the taurine inhibitor, beta-alanine, exhibited a 57% reduction in the infarct size-to-risk area ratio. The degree of cardioprotection was found to correlate (r = 0.85) with the extent of taurine depletion, the latter dependent on the length of beta-alanine feeding. When the taurine-depleted rats were fed taurine, myocardial taurine levels were restored and the cardioprotection was lost. However, addition of neither beta-alanine (3%) nor taurine (20 mM) to the perfusion medium altered infarct size. We conclude that taurine depletion renders the heart resistant to injury caused by regional ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362266     DOI: 10.1152/ajpheart.1997.273.4.H1956

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Effect of hypernatremia on injury caused by energy deficiency: role of T-type Ca2+ channel.

Authors:  Viktor Pastukh; Hairu Chen; Songwei Wu; Chian Ju Jong; Mikhail Alexeyev; Stephen W Schaffer
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

2.  Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning.

Authors:  Viktor Pastukh; Craig Ricci; Viktoriya Solodushko; Mahmood Mozaffari; Stephen W Schaffer
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation.

Authors:  Eimear Dolan; Paul A Swinton; Vitor de Salles Painelli; Benedict Stephens Hemingway; Bruna Mazzolani; Fabiana Infante Smaira; Bryan Saunders; Guilherme G Artioli; Bruno Gualano
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

4.  Role of taurine in the vasculature: an overview of experimental and human studies.

Authors:  Worku Abebe; Mahmood S Mozaffari
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 5.  Physiological roles of taurine in heart and muscle.

Authors:  Stephen W Schaffer; Chian Ju Jong; K C Ramila; Junichi Azuma
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.

Authors:  Chian Ju Jong; Takashi Ito; Mahmood Mozaffari; Junichi Azuma; Stephen Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

7.  Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Champa Patel; Hereward Wimborne; Jun Yao Liu; Stephen W Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

8.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

9.  Intracellular taurine deficiency impairs cardiac contractility in rainbow trout (Oncorhynchus mykiss) without affecting aerobic performance.

Authors:  M A Gates; A J Morash; S G Lamarre; T J MacCormack
Journal:  J Comp Physiol B       Date:  2021-09-28       Impact factor: 2.200

Review 10.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.